Short follicular phase of stimulation following corifollitropin alfa or daily recombinant FSH treatment does not compromise clinical outcome: a retrospective.

Slides:

Advertisements

Similar presentations

J. Ben-Nagi, J. Miell, D. Mavrelos, J. Naftalin, C. Lee, D. Jurkovic

Advertisements

GnRH agonist and GnRH antagonist protocols in ovarian stimulation: differential regulation pathway of aromatase expression in human granulosa cells Mohamad.

E.H. Duran, D. Dowling-Lacey, S. Bocca, L. Stadtmauer, S. Oehninger

Mostafa Metwally, Cynthia M. Farquhar, Tin Chiu Li

T. Murto, A. Skoog Svanberg, A. Yngve, T. K. Nilsson, S. Altmäe, K

Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis Sesh Kamal Sunkara, Jyotsna Pundir,

Modified natural cycle IVF and mild IVF: a 10 year Swedish experience

Kay Neumann, Georg Griesinger Reproductive BioMedicine Online

Blastocyst-stage versus cleavage-stage embryo transfer in women with high oestradiol concentrations: randomized controlled trial Eman A. Elgindy, Ahmed.

Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase TG Lainas, IA Sfontouris, IZ Zorzovilis, GK Petsas,

J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F

J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F

Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response William L. Ledger, Bart C.J.M. Fauser, Paul.

Mid-luteal progesterone concentrations are associated with live birth rates during ovulation induction J.-C. Arce, A. Balen, P. Platteau, G. Pettersson,

Can the fall in serum FSH during coasting in IVF/ICSI predict clinical outcomes? Adrija Kumar Datta, Ariel Zosmer, Amanda Tozer, Luca Sabatini, Colin.

Socio-economic disparities in access to assisted reproductive technologies in Australia Katie Harris, Hugh Burley, Robert McLachlan, Mark Bowman, Alan.

Bruce S. Shapiro, Said T. Daneshmand, Humberto Restrepo, Forest C

Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF Bart C.J.M. Fauser, Michael.

Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate Claus Yding Andersen,

No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH George Griesinger, Daniel B. Shapiro, Efstratios.

Bio-equivalent doses of recombinant HCG and recombinant LH during ovarian stimulation result in similar oestradiol output: a randomized controlled study

Management of ovarian stimulation for IVF: narrative review of evidence provided for World Health Organization guidance Cindy Farquhar, Jane Marjoribanks,

Publication productivity in IVF in Europe, 1990–2006

Circulating concentration of stem cell factor in serum of stimulated IVF patients Ali Salmassi, Sandy Zorn, Liselotte Mettler, Kerstin Koch, Walter Jonat,

Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol) Yanping Kuang, Qiuju Chen,

New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation Giovanna Sighinolfi,

Impact of high serum progesterone during the late follicular phase on IVF outcome Charlotte Sonigo, Géraldine Dray, Clémence Roche, Isabelle Cédrin-Durnerin,

Why are reproductive cancers more common in nulliparous women?

Utility of age-specific serum anti-Müllerian hormone concentrations

Maternal concentrations of human chorionic gonadotrophin in very early IVF pregnancies and duration of pregnancy: a follow-up study Tom G. Tanbo, Manuela.

Christine L Cook, M. D. , Yong Siow, Ph. D. , Susan Taylor, B. A

Novel aspects of the endocrinology of the menstrual cycle

Ongoing pregnancies from early retrieval of prematurely developing antral follicles after DHEA supplementation Murat Sönmezer, Aylin Pelin Çil, Kutluk.

Chief editor's 2017 annual report

Effect of energy expenditure and physical activity on the outcomes of assisted reproduction treatment Mert Kucuk, Fadime Doymaz, Bulent Urman Reproductive.

Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysis Georg Griesinger, Robert Boostanfar, Keith.

J. Ben-Nagi, J. Miell, D. Mavrelos, J. Naftalin, C. Lee, D. Jurkovic

M. Dieterich, M. Bolz, T. Reimer, S. Costagliola, B. Gerber

Steroid profiles by liquid chromatography-mass spectrometry of matched serum and single dominant ovarian follicular fluid from women undergoing IVF Kirsty.

Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial Vivian Chi Yan Lee, Carina Chi Wai Chan,

Mostafa Metwally, Cynthia M. Farquhar, Tin Chiu Li

Ronit Machtinger, Raoul Orvieto Reproductive BioMedicine Online

Follicular flushing in natural cycle IVF does not affect the luteal phase – a prospective controlled study M. von Wolff, A. Kohl Schwartz, P. Stute,

A retrospective analysis of ovarian stimulation with letrozole in women undergoing artificial insemination by donor X.J. Sun, L. Jiang, L.C. Ji, R. Nie,

Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trial Juan Antonio García-Velasco, Sanja.

A unique biological in-vivo model to evaluate follicular development during in-vitro maturation treatment S.E. Elizur, W.Y. Son, H. Clarke, D. Morris,

Michael J. Levy, William Ledger, Efstratios M. Kolibianakis, Pieta C

Intra-cycle variation of the uterine cavity indentation assessed with three-dimensional ultrasound in natural and stimulated cycles Sotirios H. Saravelos,

LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles Kevin Doody, Paul Devroey, Keith Gordon, Han Witjes, Bernadette Mannaerts

A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin.

Does ovarian stimulation regimen affect IVF outcome

Stephen C. Collins, Esther Chan Reproductive BioMedicine Online

Anna Pia Ferraretti, Paul Devroey, M. Cristina Magli, Luca Gianaroli

GnRH antagonist pre-treatment: one centre's experience for IVF–ICSI cycle scheduling Veronique Viardot-Foucault, Sadhana Nadarajah, Weng Kit Lye, Heng.

Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature Micah J. Hill, Gary Levy, Eric D. Levens

Genome-wide analysis shows no genomic predictors of ovarian response to stimulation by exogenous FSH for IVF Jeroen van Disseldorp, Lude Franke, Rene.

The Alpha Consensus Meeting on the professional status of the clinical embryologist: proceedings of an expert meeting Reproductive BioMedicine Online

FMR1 and AKT/mTOR signalling pathways: potential functional interactions controlling folliculogenesis in human granulosa cells Julia Rehnitz, Diego D.

C Almeida, M Sousa, A Barros Reproductive BioMedicine Online

Progesterone elevation on the day of HCG administration may affect rescue ICSI Bo Huang, Zhou Li, Lixia Zhu, Dan Hu, Qun Liu, Guijin Zhu, Hanwang Zhang

Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility C.M. Howles, V. Alam, D. Tredway, R. Homburg,

Nadine M. P. Daan, Annemieke Hoek, Eva Corpeleijn, Marinus J. C

Norbert Gleicher, Andrea Weghofer, David H. Barad

Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH Basil C. Tarlatzis,

Live birth following early follicular phase oocyte collection and vitrified-warmed embryo transfer 8 days later Safak Hatırnaz, Ebru Hatırnaz, Baris.

Implantation of fresh and thawed–warmed embryos in single embryo transfer cycles: interpreting the initial beta-HCG Cynthia K. Sites, Peter St Marie,

Randomized controlled trial of benzocaine versus placebo spray for pain relief at hysterosalpingogram E.A. Bachman, S. Senapati, M.D. Sammel, S.K. Kalra

Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics.

Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era? Antonio La Marca, Martina Capuzzo Reproductive.

High oestradiol concentration after ovarian stimulation is associated with lower maternal serum beta-HCG concentration and neonatal birth weight Suying.

Presentation transcript:

Short follicular phase of stimulation following corifollitropin alfa or daily recombinant FSH treatment does not compromise clinical outcome: a retrospective analysis of the Engage trial Tonko Mardešič, Bernadette Mannaerts, Mostafa Abuzeid, Michael Levy, Han Witjes, Bart C.J.M. Fauser Reproductive BioMedicine Online Volume 28, Issue 4, Pages 462-468 (April 2014) DOI: 10.1016/j.rbmo.2013.12.009 Copyright © 2014 Reproductive Healthcare Ltd. Terms and Conditions

Figure 1 Number of follicles ⩾11mm during stimulation with corifollitropin alfa (A) and recombinant FSH (B) in early and normal responders. Horizontal lines indicate medians, boxes indicate interquartile ranges and whiskers indicate 5th and 95th percentiles. HCG=day of human chorionic gonadotrophin. Reproductive BioMedicine Online 2014 28, 462-468DOI: (10.1016/j.rbmo.2013.12.009) Copyright © 2014 Reproductive Healthcare Ltd. Terms and Conditions

Figure 2 Serum FSH (A and B) and LH (C and D) concentrations during stimulation with corifollitropin alfa (A and C) or recombinant FSH (B and D) in early responders and normal responders. Horizontal lines indicate medians, boxes indicate interquartile ranges and whiskers indicate 5th and 95th percentiles. HCG=day of human chorionic gonadotrophin. Reproductive BioMedicine Online 2014 28, 462-468DOI: (10.1016/j.rbmo.2013.12.009) Copyright © 2014 Reproductive Healthcare Ltd. Terms and Conditions

Figure 3 Serum oestradiol (A and B), inhibin B (C and D) and progesterone (E and F) concentrations during stimulation with corifollitropin alfa (A, C, E) or recombinant FSH (B, D, F) in early responders and normal responders. Horizontal lines indicate medians, boxes indicate interquartile ranges and whiskers indicate 5th and 95th percentiles. HCG=day of human chorionic gonadotrophin. Reproductive BioMedicine Online 2014 28, 462-468DOI: (10.1016/j.rbmo.2013.12.009) Copyright © 2014 Reproductive Healthcare Ltd. Terms and Conditions